InvestorsHub Logo
Followers 32
Posts 2805
Boards Moderated 3
Alias Born 10/24/2015

Re: NY1972 post# 240

Thursday, 05/11/2023 1:31:08 PM

Thursday, May 11, 2023 1:31:08 PM

Post# of 301
It could. Another might be the direction the company had taken. Looking at how much they have burnt through, there is not much to show for it clinically. As for the (ASGCT) abstract, preclinical and clinical data from other groups is conflicting, with some suggesting that KO might negatively affect expansion, persistence and/or function.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent DTIL News